| abstract |
The present invention relates to pharmaceutical products with antithrombotic, thrombogenesis-inhibiting or thrombosis cause-inhibiting activities. Stated more accurately, the present invention relates to pharmaceutical products which contain pharmacologically acceptable powdered extracts from green tea leaves as stable active ingredient which has an excellent inhibitory activity on the causes of thrombosis, and which are produced using an improved progressive process. The present invention provides products with antithrombotic activity which contain an extract from green tea as active ingredient and conventional ancillary substances which are generally used for pharmaceutical products, such as vehicles, diluents, antioxidants etc., and furthermore a process for the production thereof. <IMAGE> |